echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > What's new in Down syndrome?

    What's new in Down syndrome?

    • Last Update: 2020-02-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, researchers from Montreal University and other institutions have found a new mechanism related to Down's syndrome The findings of the study are published in the journal Current Biology Down syndrome (SD), also known as trisomy 21 syndrome, is a genetic disease Down's syndrome is one of the main causes of mental disability and congenital heart disease in children About one in 800 children in Canada has Down's syndrome In these patients, many genes have abnormal expression at the same time, so it is difficult to determine which genes lead to which differences In a recently published study, Professor jannic Boehm's team focused on RCAN1, which is overexpressed in the brains of Down's fetuses The team's work provides insight into how genes affect the way diseases behave The human brain is made up of hundreds of billions of cells called neurons They communicate with each other through synapses As time goes by, the ability of synaptic signal transmission to increase or decrease is called "synaptic plasticity" This is an important biological phenomenon, because it is very important for memory and learning Professor Boehm said: "there are two effects of synaptic plasticity: long-term enhancement can enhance synapses and improve the interaction between neurons; long-term inhibition can weaken the ability of synaptic signal transmission." "We already know that synaptic plasticity is affected by certain proteins," said Anthony dudilot, one of the first authors of the study For example, calcineurin is inhibited during induction of long-term potentiation, but activated at the beginning of long-term inhibition However, the molecular mechanism of calcineurin regulation is not clear The team found that the various signaling pathways that trigger synaptic enhancement or inhibition can converge to the RCAN1 molecule They also determined that the gene has the ability to inhibit or promote calcineurin activity Given its dual role as an inhibitor / promoter, the researchers concluded that RCAN1 acts as a "switch" regulating synaptic plasticity, thereby affecting learning and memory.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.